News
November 5, 2015
ARC Poster Presentation
This poster detailed the experience of hereditary ATTR and wild-type TTR amyloidosis patients. It outlines the significant challenges for obtaining a correct diagnosis and access to appropriate therapy.
The poster was shown at the 1st European Congress on Hereditary ATTR amyloidosis on November 3rd, 2015.
See the poster
- Categories
- Lastest Posts
- ARC Launches Clinical Fellowship Program to Advance Amyloidosis Care
- The More Things Change, the More They Stay the Same
- The Inflation Reduction Act: The Devil is in the Details for Patients with Rare Diseases
- FDA Approves WAINUA™ (Eplontersen) for Treatment of Hereditary ATTR Amyloidosis Polyneuropathy
